These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 26147593

  • 1. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation.
    Akbas A, Tiede C, Lemound J, Maecker-Kolhoff B, Kreipe H, Hussein K.
    Transpl Int; 2015 Nov; 28(11):1299-307. PubMed ID: 26147593
    [Abstract] [Full Text] [Related]

  • 2. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 4. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 5. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H, Taheri S.
    Ann Transplant; 2011 Jun; 16(1):109-16. PubMed ID: 21436784
    [Abstract] [Full Text] [Related]

  • 6. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE, Picarsic J, Swerdlow SH, Pantanowitz L.
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [Abstract] [Full Text] [Related]

  • 7. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 8. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [Abstract] [Full Text] [Related]

  • 9. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
    Ali S, AlThubaiti S, Renzi S, Krueger J, Chiang KY, Naqvi A, Schechter T, Punnett A, Ali M.
    Pediatr Transplant; 2019 Feb; 23(1):e13319. PubMed ID: 30417487
    [Abstract] [Full Text] [Related]

  • 10. Post-transplant lymphoproliferative disorders are not associated with IgG4 sclerosing disease.
    Cathro HP, Bullock GC, Bonatti H, Meriden Z, Cook S, Aguilera N.
    Transpl Infect Dis; 2014 Dec; 16(6):897-903. PubMed ID: 25298125
    [Abstract] [Full Text] [Related]

  • 11. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 12. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M, Thakral B, Yohe S, Balfour HH, Singh C, Spears M, McKenna RW.
    Am J Surg Pathol; 2014 Nov 15; 38(11):1522-9. PubMed ID: 25007145
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T, Zwick DL, Rothberg PG, Warady BA.
    Pediatr Nephrol; 1999 Nov 15; 13(9):748-54. PubMed ID: 10603113
    [Abstract] [Full Text] [Related]

  • 14. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 15; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 15. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
    Deng Z, Jiang L, Zhou T, Shen C, Chen Q, Xia Q.
    Zhonghua Er Ke Za Zhi; 2014 Aug 15; 52(8):579-82. PubMed ID: 25224233
    [Abstract] [Full Text] [Related]

  • 16. Risk factors and prognosis in T-cell posttransplantation lymphoproliferative diseases: reevaluation of 163 cases.
    Tiede C, Maecker-Kolhoff B, Klein C, Kreipe H, Hussein K.
    Transplantation; 2013 Feb 15; 95(3):479-88. PubMed ID: 23296147
    [Abstract] [Full Text] [Related]

  • 17. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 18. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.
    Lones MA, Mishalani S, Shintaku IP, Weiss LM, Nichols WS, Said JW.
    Hum Pathol; 1995 May 15; 26(5):525-30. PubMed ID: 7750936
    [Abstract] [Full Text] [Related]

  • 19. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 15; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for adenotonsillar hypertrophy in children following solid organ transplantation.
    Shapiro NL, Strocker AM, Bhattacharyya N.
    Int J Pediatr Otorhinolaryngol; 2003 Feb 15; 67(2):151-5. PubMed ID: 12623151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.